© 2005 Oxford University Press
ARTICLE |
Coffee, Tea, and Caffeine Consumption and Incidence of Colon and Rectal Cancer
Affiliation of authors: Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, and Harvard Medical School (KBM); Departments of Epidemiology (KBM, WCW, EG) and Nutrition (WCW, EG), Harvard School of Public Health, Boston; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston (KBM, WCW, CSF, EG); Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA (CSF)
Correspondence to: Karin B. Michels, ScD, Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, 221 Longwood Ave., Boston, MA 02115 (e-mail: kmichels{at}rics.bwh.harvard.edu).
Background: Frequent coffee consumption has been associated with a reduced risk of colorectal cancer in a number of case–control studies. Cohort studies have not revealed such an association but were limited in size. We explored the association between consumption of coffee and tea and the incidence of colorectal cancer in two large prospective cohorts of women and men. Methods: We used data from the Nurses' Health Study (women) and the Health Professionals' Follow-up Study (men). Consumption of coffee and tea and total caffeine intake were assessed and updated in 1980, 1984, 1986, 1990, and 1994 among women and in 1986, 1990, and 1994 among men. The incidence of cancer of the colon or rectum was ascertained through 1998. Hazard ratios were calculated using Cox proportional hazards models that adjusted for potential confounders. All tests of statistical significance were two-sided. Results: During almost 2 million person-years of follow-up, 1438 cases of colorectal cancer were observed. Consumption of caffeinated coffee or tea with caffeine or caffeine intake was not associated with the incidence of colon or rectal cancer in either cohort. For both cohorts combined, the covariate-adjusted hazard ratio for colorectal cancer associated with consumption of each additional cup of caffeinated coffee was 0.99 (95% confidence interval [CI] = 0.96 to 1.03). However, participants who regularly consumed two or more cups of decaffeinated coffee per day had a 52% (95% CI = 19% to 71%) lower incidence of rectal cancer than those who never consumed decaffeinated coffee. Conclusions: Consumption of caffeinated coffee, tea with caffeine, or caffeine was not associated with incidence of colon of rectal cancer, whereas regular consumption of decaffeinated coffee was associated with a reduced incidence of rectal cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
Related Memo to the Media
- Press Release: Studies Examine Coffee Drinking and Risk of Liver and Colorectal Cancers
- Sarah L. Zielinski
J Natl Cancer Inst 2005 97: 241.[Extract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  L. Wang, I-M. Lee, S. M Zhang, J. B Blumberg, J. E Buring, and H. D Sesso Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women Am. J. Clinical Nutrition, March 1, 2009; 89(3): 905 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Naganuma, S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, Y. Nishino, A. Fukao, and I. Tsuji Coffee Consumption and the Risk of Oral, Pharyngeal, and Esophageal Cancers in Japan: The Miyagi Cohort Study Am. J. Epidemiol., December 15, 2008; 168(12): 1425 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Arab and J. B. Blumberg Proceedings of the Fourth International Scientific Symposium on Tea and Human Health. September 18, 2007. Washington, DC, USA. J. Nutr., August 1, 2008; 138(8): 1526S - 1588S. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Rowe, M. P. Nantz, J. F. Bukowski, and S. S. Percival Specific Formulation of Camellia sinensis Prevents Cold and Flu Symptoms and Enhances {gamma}{delta} T Cell Function: A Randomized, Double-Blind, Placebo-Controlled Study J. Am. Coll. Nutr., October 1, 2007; 26(5): 445 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. Sun, J.-M. Yuan, W. P. Koh, H.-P. Lee, and M. C. Yu Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study Carcinogenesis, October 1, 2007; 28(10): 2143 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Merighi, A. Benini, P. Mirandola, S. Gessi, K. Varani, C. Simioni, E. Leung, S. Maclennan, P. G. Baraldi, and P. A. Borea Caffeine Inhibits Adenosine-Induced Accumulation of Hypoxia-Inducible Factor-1{alpha}, Vascular Endothelial Growth Factor, and Interleukin-8 Expression in Hypoxic Human Colon Cancer Cells Mol. Pharmacol., August 1, 2007; 72(2): 395 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ogino, T. Kawasaki, G. J. Kirkner, P. Kraft, M. Loda, and C. S. Fuchs Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample J. Mol. Diagn., July 1, 2007; 9(3): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yang, X.-O. Shu, H. Li, W.-H. Chow, B.-T. Ji, X. Zhang, Y.-T. Gao, and W. Zheng Prospective Cohort Study of Green Tea Consumption and Colorectal Cancer Risk in Women Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1219 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, S. M. Zhang, K. Wu, W. C. Willett, C. S. Fuchs, and E. Giovannucci Flavonoid Intake and Colorectal Cancer Risk in Men and Women Am. J. Epidemiol., October 1, 2006; 164(7): 644 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Sun, J.-M. Yuan, W.-P. Koh, and M. C. Yu Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies Carcinogenesis, July 1, 2006; 27(7): 1301 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Larsson, L. Bergkvist, E. Giovannucci, and A. Wolk Coffee Consumption and Incidence of Colorectal Cancer in Two Prospective Cohort Studies of Swedish Women and Men Am. J. Epidemiol., April 1, 2006; 163(7): 638 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ju, J. Hong, J.-n. Zhou, Z. Pan, M. Bose, J. Liao, G.-y. Yang, Y. Y. Liu, Z. Hou, Y. Lin, et al. Inhibition of Intestinal Tumorigenesis in Apcmin/+ Mice by (-)-Epigallocatechin-3-Gallate, the Major Catechin in Green Tea Cancer Res., November 15, 2005; 65(22): 10623 - 10631. [Abstract] [Full Text] [PDF]
|
|